Lipid parameters, adipose tissue distribution and prognosis prediction in chronic kidney Disease patients

被引:5
作者
Chen, Hui-fen [1 ]
Xiao, Bing-jie [1 ]
Chen, Lin-yi [1 ]
Ouyang, Wen-wei [2 ,3 ]
Zhang, Xian-long [4 ]
He, Zhi-ren [4 ]
Fu, Li-zhe [5 ]
Tang, Fang [5 ]
Tang, Xiao-na [6 ]
Liu, Xu-sheng [1 ,4 ]
Wu, Yi-fan [1 ,4 ,5 ]
机构
[1] Guangzhou Univ Chinese Med, Clin Coll 2, Guangzhou, Guangdong, Peoples R China
[2] Guangzhou Univ Chinese Med, Affiliated Hosp 2, Guangdong Prov Hosp Chinese Med, Key Unit Methodol Clin Res, Guangzhou, Peoples R China
[3] Karolinska Inst, Dept Global Publ Hlth, Global Hlth Hlth Syst & Policy, Stockholm, Sweden
[4] Guangzhou Univ Chinese Med, Affiliated Hosp 2, Guangdong Prov Hosp Chinese Med, Renal Div, Guangzhou, Guangdong, Peoples R China
[5] Guangzhou Univ Chinese Med, Affiliated Hosp 2, Guangdong Prov Hosp Chinese Med, Chron Dis Management Outpatient Clin, Guangzhou, Peoples R China
[6] Guangzhou Univ Chinese Med, Baoan Tradit Chinese Med Hosp, Shenzhen, Peoples R China
关键词
Chronic kidney disease; Lipid profiles; Lipid distribution; BODY-MASS INDEX; CKD; OBESITY; ASSOCIATION; PROGRESSION; MORTALITY; COHORT;
D O I
10.1186/s12944-024-02004-4
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
BackgroundLipid management in clinic is critical to the prevention and treatment of Chronic kidney disease (CKD), while the manifestations of lipid indicators vary in types and have flexible association with CKD prognosis.PurposeExplore the associations between the widely used indicators of lipid metabolism and their distribution in clinic and CKD prognosis; provide a reference for lipid management and inform treatment decisions for patients with non-dialysis CKD stage 3-5.MethodsThis is a retrospective cohort study utilizing the Self-Management Program for Patients with Chronic Kidney Disease Cohort (SMP-CKD) database of 794 individuals with CKD stages 3-5. It covers demographic data, clinical diagnosis and medical history collection, laboratory results, circulating lipid profiles and lipid distribution assessments. Primary endpoint was defined as a composite outcome(the initiation of chronic dialysis or renal transplantation, sustained decline of 40% or more in estimated glomerular filtration rate (eGFR), doubled of serum creatinine (SCr) from the baseline, eGFR less than 5 mL/min/1.73m2, or all-cause mortality). Exposure variables were circulating lipid profiles and lipid distribution measurements. Association were assessed using Relative risks (RRs) (95% confidence intervals (CIs)) computed by multivariate Poisson models combined with least absolute shrinkage and selection operator (LASSO) regression according to categories of lipid manifestations. The best model was selected via akaike information criterion (AIC), area under curve (AUC), receiver operating characteristic curve (ROC) and net reclassification index (NRI). Subgroup analysis and sensitivity analysis were performed to assess the interaction effects and robustness..Results255 individuals reached the composite outcome. Median follow-up duration was 2.03 [1.06, 3.19] years. Median age was 58.8 [48.7, 67.2] years with a median eGFR of 33.7 [17.6, 47.8] ml/min/1.73 m2. Five dataset were built after multiple imputation and five category-based Possion models were constructed for each dataset. Model 5 across five datasets had the best fitness with smallest AIC and largest AUC. The pooled results of Model 5 showed that total cholesterol (TC) (RR (95%CI) (per mmol/L) :1.143[1.023,1.278], P = 0.018) and percentage of body fat (PBF) (RR (95%CI) (per percentage):0.976[0.961,0.992], P = 0.003) were significant factors of composite outcome. The results indicated that comprehensive consideration of lipid metabolism and fat distribution is more critical in the prediction of CKD prognosis..ConclusionComprehensive consideration of lipid manifestations is optimal in predicting the prognosis of individuals with non-dialysis CKD stages 3-5.
引用
收藏
页数:9
相关论文
共 31 条
[1]   Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017 [J].
Bikbov, Boris ;
Purcell, Carrie ;
Levey, Andrew S. ;
Smith, Mari ;
Abdoli, Amir ;
Abebe, Molla ;
Adebayo, Oladimeji M. ;
Afarideh, Mohsen ;
Agarwal, Sanjay Kumar ;
Agudelo-Botero, Marcela ;
Ahmadian, Elham ;
Al-Aly, Ziyad ;
Alipour, Vahid ;
Almasi-Hashiani, Amir ;
Al-Raddadi, Rajaa M. ;
Alvis-Guzman, Nelson ;
Amini, Saeed ;
Andrei, Tudorel ;
Andrei, Catalina Liliana ;
Andualem, Zewudu ;
Anjomshoa, Mina ;
Arabloo, Jalal ;
Ashagre, Alebachew Fasil ;
Asmelash, Daniel ;
Ataro, Zerihun ;
Atout, Maha Moh'd Wahbi ;
Ayanore, Martin Amogre ;
Badawi, Alaa ;
Bakhtiari, Ahad ;
Ballew, Shoshana H. ;
Balouchi, Abbas ;
Banach, Maciej ;
Barquera, Simon ;
Basu, Sanjay ;
Bayih, Mulat Tirfie ;
Bedi, Neeraj ;
Bello, Aminu K. ;
Bensenor, Isabela M. ;
Bijani, Ali ;
Boloor, Archith ;
Borzi, Antonio M. ;
Camera, Luis Alberto ;
Carrero, Juan J. ;
Carvalho, Felix ;
Castro, Franz ;
Catala-Lopez, Ferran ;
Chang, Alex R. ;
Chin, Ken Lee ;
Chung, Sheng-Chia ;
Cirillo, Massimo .
LANCET, 2020, 395 (10225) :709-733
[2]  
Giri RS., 2022, CUREUS J MED SCIENCE, V14, pe25674
[3]   The current and future landscape of dialysis [J].
Himmelfarb, Jonathan ;
Vanholder, Raymond ;
Mehrotra, Rajnish ;
Tonelli, Marcello .
NATURE REVIEWS NEPHROLOGY, 2020, 16 (10) :573-585
[4]   Association between Body Mass Index and Renal Outcomes Modified by Chronic Kidney Disease and Anemia: The Obesity Paradox for Renal Outcomes [J].
Hung, Chi-Chih ;
Yu, Pei-Hua ;
Niu, Sheng-Wen ;
Kuo, I-Ching ;
Lee, Jia-Jung ;
Shen, Feng-Ching ;
Chang, Jer-Ming ;
Hwang, Shang-Jyh .
JOURNAL OF CLINICAL MEDICINE, 2022, 11 (10)
[5]   A Body Mass Index-Based Cross-Classification Approach for the Assessment of Prognostic Factors in Chronic Kidney Disease Progression [J].
Kataoka, Hiroshi ;
Ono, Kota ;
Mochizuki, Toshio ;
Hanafusa, Norio ;
Imai, Enyu ;
Hishida, Akira ;
Nitta, Kosaku .
KIDNEY & BLOOD PRESSURE RESEARCH, 2019, 44 (03) :362-383
[6]   Low HDL cholesterol as a predictor of chronic kidney disease progression: a cross-classification approach and matched cohort analysis [J].
Kawachi, Keiko ;
Kataoka, Hiroshi ;
Manabe, Shun ;
Mochizuki, Toshio ;
Nitta, Kosaku .
HEART AND VESSELS, 2019, 34 (09) :1440-1455
[7]   Paradoxical association between body mass index and mortality in men with CKD not yet on dialysis [J].
Kovesdy, Csaba P. ;
Anderson, John E. ;
Kalantar-Zadeh, Kamyar .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2007, 49 (05) :581-591
[8]   Updates in hyperkalemia: Outcomes and therapeutic strategies [J].
Kovesdy, Csaba P. .
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS, 2017, 18 (01) :41-47
[9]   Longitudinal Weight Change During CKD Progression and Its Association With Subsequent Mortality [J].
Ku, Elaine ;
Kopple, Joel D. ;
Johansen, Kirsten L. ;
McCulloch, Charles E. ;
Go, Alan S. ;
Xie, Dawei ;
Lin, Feng ;
Hamm, L. Lee ;
He, Jiang ;
Kusek, John W. ;
Navaneethan, Sankar D. ;
Ricardo, Ana C. ;
Rincon-Choles, Hernan ;
Smogorzewski, Miroslaw ;
Hsu, Chi-yuan .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2018, 71 (05) :657-665
[10]   Low-density lipoprotein cholesterol levels and adverse clinical outcomes in chronic kidney disease: Results from the KNOW-CKD [J].
Lee, Changhyun ;
Park, Jung Tak ;
Chang, Tae-Ik ;
Kang, Ea Wha ;
Nam, Ki Heon ;
Joo, Young Su ;
Sung, Su-Ah ;
Kim, Yeong Hoon ;
Chae, Dong-Wan ;
Park, Su Kyung ;
Ahn, Curie ;
Oh, Kook-Hwan ;
Yoo, Tae-Hyun ;
Kang, Shin-Wook ;
Han, Seung Hyeok .
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2022, 32 (02) :410-419